Validation of Novel Therapeutic Targets for Huntingtons Disease (R01)
Published Date
Agency
CFDA
93.853
Contact Information
Tijuanna Decoster, 301-496-9231; td18k@nih.gov
Deadline
Department
Eligiblity
State, local and tribal governments, institutions of higher education, nonprofit and for-profit organizations, and public and Indian housing authorities
Guide Page Reference
None
More Information
Program Area
Programe Purpose
To validate novel molecular targets for disease-modifying therapeutic intervention in Huntingtons disease
